Photo of Vinita Sehgal

Vinita Sehgal

Print ProfilePrint Profile


  • Nephrology


  • American Board of Internal Medicine


  • MD, Yale University School of Medicine

  • Residency, Internal Medicine
    Columbia-Presbyterian Medical Ctr.

  • Fellowship, Nephrology
    Columbia-Presbyterian Medical Ctr.

  • Fellowship, Nephrology Transplant
    Columbia-Presbyterian Medical Ctr.


    Dr. Sehgal earned her M.D. at Yale University School of Medicine and went on to do her residency in Internal Medicine at Columbia-Presbyterian Medical Center here in New York City. She completed a fellowship in Nephrology and a fellowship in Transplant Nephrology also at Columbia-Presbyterian. Among her many honors, Dr. Sehgal was recognized as a John Harvard Scholar at Harvard University in 1986 where she graduated Cum Laude. Dr. Sehgal is board certified in Internal Medicine and Nephrology.

    Dr. Sehgal's society memberships include the American Society of Nephrology, American College of Physicians and the New York State Society of Nephrology.


Transplant nephrology

Clinical research interest in the medical complications of transplantation, including hepatitis C, post-transplant diabetes, bone disease, and hypercoagulable states.


Sehgal V, Radhakrishnan J, Appel GB, Valeri A, Cohen DJ. Progressive renal insufficiency following cardiac transplantation:cyclosporine, lipids, and hypertension. Am J Kidney Dis 1995; 26(1): 193-201.

Goldstein DI, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen DJ. Cyclosporine-associated end-stage nephropathy after cardiac transplantation:incidence and progression. Transplantation 1997; 63(5): 664-668.

Akalin E, Ames S, Sehgal V, Fotino M, Daly L, Murphy B, Bromberg JS. Intravenous Immunoglobulin and thymoglobulin facilitate kidney transplantation in complement dependent cytotoxicity B cell and flow cytometry (T and/or B cell) cross-match positive patients. Transplantation 2003; 76(10): 1444-1447.

Akalin E, Sehgal V, Ames S, Hossain S, Daly L, Murphy B, Bromberg JS. Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis. American Journal of Transplantation 2003; 3(6): 731-735.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Sehgal did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central

Department of Medicine-Renal Transplant Medicine

5 East 98th Street
12th Floor
New York, NY 10029

Tel: 212-659-8086
Fax: 212-348-2474
Get Directions

Office Hours:
  • Monday 9:00am - 5:00pm
  • Tuesday 9:00am - 5:00pm
  • Wednesday 9:00am - 5:00pm
  • Thursday 9:00am - 5:00pm
  • Friday 9:00am - 5:00pm
Insurance Plans
  • Aetna
  • Anthem Health
  • Blue Choice
  • Devon Health Services
  • Empire Blue Cross/Blue Shield - PPO
  • Fidelis Care NY - HMO
  • GHI HMO Select, Inc.
  • Health Insurance Plan (HIP)
  • Island Group
  • Medicaid
  • Medicare
  • PHS/Healthnet/Guardian
  • Prem Preferred Care/Beechstreet
  • Private Healthcare Systems (PHCS)
  • Railroad Medicare
  • SelectPRO
  • United Healthcare
  • United Healthcare Empire Plan
  • Workers' Compensation